Decreasing matrix modulus of PEG hydrogels induces a vascular phenotype in human cord blood stem cells

Biomaterials

Volumn 62, Issue , 2015, Pages 24-34

  Mahadevaiah, Shruthi ^a   Robinson, Karyn G ^a   Kharkar, Prathamesh M ^b   Kiick, Kristi L ^b   Akins, Robert E ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cell encapsulation; Gene expression; Stem cell; Vascular grafts; VWF (von Willibrand factor)

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; CARDIOVASCULAR SURGERY; CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; GELS; GENE EXPRESSION; GRAFTS; HYDROGELS; STEM CELLS;

CARDIO-VASCULAR DISEASE; CELL ENCAPSULATIONS; CORD BLOOD STEM CELLS; EXPRESSION PROFILING; IMMUNOMAGNETIC SEPARATION; UMBILICAL CORD BLOOD; VASCULAR GRAFTS; VWF (VON WILLIBRAND FACTOR);

CELL SIGNALING;

FIBRONECTIN; GELATIN; MACROGOL; BIOMATERIAL; HYDROGEL; MACROGOL DERIVATIVE;

ADDITION REACTION; ADVENTITIA; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL GRAFT; CD34+ STEM CELL; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL VIABILITY; CELLS BY BODY ANATOMY; CONTROLLED STUDY; CROSS LINKING; ELASTICITY; ENGRAFTMENT; FLOW CYTOMETRY; GELATION; GENE EXPRESSION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYDROGEL; HYDROPHILICITY; IMMUNOMAGNETIC SEPARATION; MICROVASCULARIZATION; NUCLEOPHILICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIUM; BLOOD VESSEL; CHEMISTRY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FEMALE; FETUS BLOOD; GROWTH, DEVELOPMENT AND AGING; HARDNESS; MATERIALS TESTING; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; YOUNG MODULUS;

BIOCOMPATIBLE MATERIALS; BLOOD VESSELS; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; ELASTIC MODULUS; FEMALE; FETAL BLOOD; HARDNESS; HUMANS; HYDROGELS; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; POLYETHYLENE GLYCOLS;

EID: 84930788783     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.05.021     Document Type: Article

References (66)

1. Trogdon J.G., Finkelstein E.A., Nwaise I.A., Tangka F.K., Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promot. Pract. 2007, 8:234-242.
2. Fitzgibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., Burton J.R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J. Am. Coll. Cardiol. 1996, 28:616-626.
3. Goldman S., Zadina K., Moritz T., Ovitt T., Sethi G., Copeland J.G., et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J. Am. Coll. Cardiol. 2004, 44:2149-2156.
4. Shinoka T., Breuer C. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J. Biol. Med. 2008, 81:161-166.
5. Zhang W.J., Liu W., Cui L., Cao Y. Tissue engineering of blood vessel. J. Cell. Mol. Med. 2007, 11:945-957.
6. Zhao J.L., Ma C., O'Connell R.M., Mehta A., DiLoreto R., Heath J.R., et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell. Stem Cell. 2014, 14:445-459.
7. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. Official J. Soc. Neurosci. 2005, 25:4694-4705.
8. Gonfiotti A., Jaus M.O., Barale D., Baiguera S., Comin C., Lavorini F., et al. The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet 2014, 383:238-244.
9. Telukuntla K.S., Suncion V.Y., Schulman I.H., Hare J.M. The advancing field of cell-based therapy: insights and lessons from clinical trials. J. Am. Heart Assoc. 2013, 2:e000338.
10. Stanzel B.V., Liu Z., Somboonthanakij S., Wongsawad W., Brinken R., Eter N., et al. Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell. Reports 2014, 2:64-77.
11. Kanji S., Das M., Aggarwal R., Lu J., Joseph M., Pompili V.J., et al. Nanofiber-expanded human umbilical cord blood-derived CD34(+) cell therapy accelerates cutaneous wound closure in NOD/SCID mice. J. Cell. Mol. Med. 2014, 18:685-697.
12. Kanji S., Das M., Aggarwal R., Lu J., Joseph M., Basu S., et al. Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10. Stem Cell Res. 2014, 12:275-288.
13. Huang X., Sun K., Zhao Y.D., Vogel S.M., Song Y., Mahmud N., et al. Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge. PloS one 2014, 9:e88814.
14. Subrammaniyan R., Amalorpavanathan J., Shankar R., Rajkumar M., Baskar S., Manjunath S.R., et al. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience. Cytotherapy 2011, 13:993-999.
15. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 2007, 127:526-537.
16. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 2004, 56:549-580.
17. Peyton S.R., Kim P.D., Ghajar C.M., Seliktar D., Putnam A.J. The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 2008, 29:2597-2607.
18. Banerjee A., Arha M., Choudhary S., Ashton R.S., Bhatia S.R., Schaffer D.V., et al. The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells. Biomaterials 2009, 30:4695-4699.
19. Saha K., Keung A.J., Irwin E.F., Li Y., Little L., Schaffer D.V., et al. Substrate modulus directs neural stem cell behavior. Biophys. J. 2008, 95:4426-4438.
20. DeVolder R., Kong H.J. Hydrogels for in vivo-like three-dimensional cellular studies. Wiley Interdiscip. Rev. Syst. Biol. Med. 2012, 4:351-365.
21. Peyton S.R., Raub C.B., Keschrumrus V.P., Putnam A.J. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 2006, 27:4881-4893.
22. Bhattarai N., Gunn J., Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. drug Deliv. Rev. 2010, 62:83-99.
23. Jiang Y., Chen J., Deng C., Suuronen E.J., Zhong Z. Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering. Biomaterials 2014, 35:4969-4985.
24. Schmidt J.J., Rowley J., Kong H.J. Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. Part A 2008, 87:1113-1122.
25. DeVolder R.J., Kong H.J. Three dimensionally flocculated proangiogenic microgels for neovascularization. Biomaterials 2010, 31:6494-6501.
26. Robinson K.G., Nie T., Baldwin A.D., Yang E.C., Kiick K.L., Akins R.E. Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells. J. Biomed. Mater. Res. Part A 2012, 100:1356-1367.
27. Nie T., Akins R.E., Kiick K.L. Production of heparin-containing hydrogels for modulating cell responses. Acta Biomater. 2009, 5:865-875.
28. Cabrera Fischer E.I., Bia D., Camus J.M., Zocalo Y., de Forteza E., Armentano R.L. Adventitia-dependent mechanical properties of brachiocephalic ovine arteries in in vivo and in vitro studies. Acta Physiol. (Oxf) 2006, 188:103-111.
29. Wagenseil J.E., Mecham R.P. Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 2009, 89:957-989.
30. Lu X., Yang J., Zhao J.B., Gregersen H., Kassab G.S. Shear modulus of porcine coronary artery: contributions of media and adventitia. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1966-H1975.
31. Stenmark K.R., Yeager M.E., El Kasmi K.C., Nozik-Grayck E., Gerasimovskaya E.V., Li M., et al. The adventitia: essential regulator of vascular wall structure and function. Annu. Rev. Physiol. 2013, 75:23-47.
32. Ruan J.L., Tulloch N.L., Muskheli V., Genova E.E., Mariner P.D., Anseth K.S., et al. An improved cryosection method for polyethylene glycol hydrogels used in tissue engineering. Tissue Eng. Part C. Methods 2013, 19:794-801.
33. Kharkar P.M., Kiick K.L., Kloxin A.M. Designing degradable hydrogels for orthogonal control of cell microenvironments. Chem. Soc. Rev. 2013, 42:7335-7372.
34. Phelps E.A., Enemchukwu N.O., Fiore V.F., Sy J.C., Murthy N., Sulchek T.A., et al. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv. Mater. 2012, 24:64-70. 2.
35. Mather B.D., Viswanathan K., Miller K.M., Long T.E. Michael addition reactions in macromolecular design for emerging technologies. Prog. Polym. Sci. 2006, 31:487-531.
36. Schelte P., Boeckler C., Frisch B., Schuber F. Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. Bioconjugate Chem. 2000, 11:118-123.
37. Baldwin A.D., Kiick K.L. Reversible maleimide-thiol adducts yield glutathione-sensitive poly(ethylene glycol)-heparin hydrogels. Polym. Chem. 2013, 4:133-143.
38. Kharkar P.M., Kloxin A.M., Kiick K.L. Dually degradable click hydrogels for controlled degradation and protein release. J. Mater. Chem. B 2014, 2(34):5511-5521.
39. Treloar L.R.G. The Physics of Rubber Elasticity 2005, Clarendon Press ; Oxford University Press, Oxford; New York. third ed.
40. Kekarainen T., Mannelin S., Laine J., Jaatinen T. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell. Biol. 2006, 7:30.
41. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005, 16:159-178.
42. Xia Y., Bhattacharyya A., Roszell E.E., Sandig M., Mequanint K. The role of endothelial cell-bound Jagged1 in Notch3-induced human coronary artery smooth muscle cell differentiation. Biomaterials 2012, 33:2462-2472.
43. Valdimarsdottir G., Goumans M.J., Itoh F., Itoh S., Heldin C.H., ten Dijke P. Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells. BMC Cell. Biol. 2006, 7:16.
44. Mallawaarachchi C.M., Weissberg P.L., Siow R.C. Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1383-1387.
45. Brudno Y., Ennett-Shepard A.B., Chen R.R., Aizenberg M., Mooney D.J. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials 2013, 34:9201-9209.
46. Kuriyama S., Theveneau E., Benedetto A., Parsons M., Tanaka M., Charras G., et al. In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity. J. Cell. Biol. 2014, 206:113-127.
47. Butcher D.T., Alliston T., Weaver V.M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 2009, 9:108-122.
48. Chaudhuri O., Koshy S.T., Branco da Cunha C., Shin J.W., Verbeke C.S., Allison K.H., et al. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat. Mater. 2014, 13:970-978.
49. Engler A., Bacakova L., Newman C., Hategan A., Griffin M., Discher D. Substrate compliance versus ligand density in cell on gel responses. Biophys. J. 2004, 86:617-628.
50. Grimaldi A., Bianchi C., Greco G., Tettamanti G., Noonan D.M., Valvassori R., et al. In vivo isolation and characterization of stem cells with diverse phenotypes using growth factor impregnated biomatrices. PloS one 2008, 3:e1910.
51. Liu G., Li Y., Sun J., Zhou H., Zhang W., Cui L., et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng. Part A 2010, 16:971-982.
52. Evans N.D., Minelli C., Gentleman E., LaPointe V., Patankar S.N., Kallivretaki M., et al. Substrate stiffness affects early differentiation events in embryonic stem cells. Eur. Cells Mater. 2009, 18:1-13. discussion-4.
53. Oswald J., Steudel C., Salchert K., Joergensen B., Thiede C., Ehninger G., et al. Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells 2006, 24:494-500.
54. Magnusson P.U., Dimberg A., Mellberg S., Lukinius A., Claesson-Welsh L. FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. Blood 2007, 110:4214-4222.
55. Shipley J.M., Mecham R.P., Maus E., Bonadio J., Rosenbloom J., McCarthy R.T., et al. Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development. Mol. Cell. Biol. 2000, 20:4879-4887.
56. Henshall T.L., Keller A., He L., Johansson B.R., Wallgard E., Raschperger E., et al. Notch3 is necessary for blood vessel integrity in the central nervous system. Arterioscler. Thromb. Vasc. Biol. 2015, 35:409-420.
57. Roberts A.B., Sporn M.B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993, 8:1-9.
58. Orlova V.V., Liu Z., Goumans M.J., ten Dijke P. Controlling angiogenesis by two unique TGF-beta type I receptor signaling pathways. Histol. Histopathol. 2011, 26:1219-1230.
59. Cunha S.I., Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011, 117:6999-7006.
60. Larrivee B., Prahst C., Gordon E., del Toro R., Mathivet T., Duarte A., et al. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev. Cell 2012, 22:489-500.
61. Gaebel R., Furlani D., Sorg H., Polchow B., Frank J., Bieback K., et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PloS one 2011, 6:e15652.
62. Liu Z., Lebrin F., Maring J.A., van den Driesche S., van der Brink S., van Dinther M., et al. ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis. PloS one 2014, 9:e86273.
63. Dombrowski C., Helledie T., Ling L., Grunert M., Canning C.A., Jones C.M., et al. FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1). Stem Cells 2013, 31:2724-2736.
64. Boulton M.E., Cai J., Grant M.B. Gamma-secretase: a multifaceted regulator of angiogenesis. J. Cell. Mol. Med. 2008, 12:781-795.
65. Avery S., Zafarana G., Gokhale P.J., Andrews P.W. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 2010, 28:863-873.
66. Rorby E., Hagerstrom M.N., Blank U., Karlsson G., Karlsson S. Human hematopoietic stem/progenitor cells overexpressing Smad4 exhibit impaired reconstitution potential in vivo. Blood 2012, 120:4343-4351.